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A B S T R A C T
Small interfering RNA (siRNA) can induce RNA interference, which leads to the knockdown of messenger RNA
(mRNA) and protein. As a result, siRNA is often used in vitro and in vivo to unravel the function of genes and as a
therapeutic agent to disrupt excessive expression of disease-related genes. However, there is a large gap between
in vitro and in vivo models in terms of simplicity, flexibility, throughput, and translatability. This gap could be
bridged by using precision-cut tissue slices, which represent viable explants prepared from animal or human
tissue that can be cultured ex vivo. Previously, we demonstrated that self-deliverable siRNA (Accell siRNA)
induced significant mRNA knockdown in lung slices. The goal of this study, however, was to investigate whether
Accell siRNA also induced protein knockdown in murine lung slices. Slices were incubated for up to 96 h with no
siRNA (untransfected), non-targeting siRNA (control), or gene-targeting siRNA (Gapdh, Ppib, Serpinh1, and
Bcl2l1). Overall, untransfected and transfected slices remained viable during an incubation of 96 h. In addition,
gene-targeting siRNAs induced not only significant and specific mRNA knockdown but also protein knockdown.
Finally, protein knockdown of fibrogenesis-related targets (Ppib, Serpinh1, and Bcl2l1) was shown to influence
fibrogenesis on mRNA level, thereby demonstrating this model its utility in functional genomics and transla-
tional research.
1. Introduction
Small interfering RNA (siRNA) is a class of double-stranded RNA
molecules that can induce RNA interference (RNAi) – a process that
leads to the transient knockdown of specific gene products, such as
messenger RNA (mRNA) and protein [1]. Because siRNA can be used to
knockdown virtually every gene, researchers can deduce the function of
genes based on observed phenotypic changes [2]. siRNA can also be
used therapeutically to disrupt excessive expression of disease-related
genes, such as collagen expression in fibrosis or oncogene expression in
cancer [3]. Although RNAi continues to be an indispensable tool in
functional genomics and drug development, it remains crucial to select
appropriate experimental models [4]. For example, there is a large
translational gap between in vitro and in vivo models in terms of sim-
plicity, flexibility, throughput, and translatability [5]. Novel experi-
mental models, which combine advantages of in vitro and in vivo
models, are therefore greatly desired.
This need could be addressed by using precision-cut tissue slices
which are viable explants with a well-defined thickness and diameter,
prepared from animal or human tissue (e.g. lungs, kidney, liver, and
intestine), that can be cultured ex vivo [6]. An important advantage of
this model is that the structural and functional heterogeneity of organs
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is conserved, partly due to the presence of cell-matrix and intercellular
interactions. To that end, tissue slices appear to be a promising ex-
perimental model to assess the biological effects of siRNA in relevant
biological environments. We previously demonstrated that self-deli-
verable siRNA (Accell siRNA) disrupted mRNA expression in lung and
kidney slices prepared from murine tissue [5]. Although significant
mRNA knockdown (55%) was achieved after an incubation of 48 h,
protein knockdown was not observed (Supplementary Fig. 1). This
discrepancy between mRNA and protein levels could have been caused
by differences in their respective intracellular half-lives. Longer in-
cubation times may be required for protein levels to reflect changes in
mRNA levels.
Supplementary data associated with this article can be found, in the
online version, at https://doi.org/10.1016/j.ejpb.2018.11.005.
Full potential of this transfection model can only be realized if
knockdown of protein is also demonstrated. Therefore, the main goal of
this study was to further characterize and optimize this transfection
model to achieve protein knockdown in murine lung slices using Accell
siRNA. First, we identified whether untransfected and transfected slices
remained viable during an incubation of 96 h. The investigated viability
parameters included the adenosine triphosphate (ATP), protein, and
RNA content as well as morphology. Next, we analyzed whether various
Accell siRNAs (targeting Gapdh, Ppib, Serpinh1, or Bcl2l1) induced
mRNA and protein knockdown. mRNA knockdown was studied by real-
time quantitative polymerase chain reaction (qPCR), whereas protein
knockdown was investigated by western blotting. Finally, as Ppib,
Serpinh1, and Bcl2l1 are involved in fibrogenesis, we determined whe-
ther protein knockdown affected the fibrogenic phenotype of slices
[7–9]. To that end, we assessed mRNA expression of the following
markers: Serpine1, Tnfrsf11b, Fn, Col1a1, and Acta2 [10–15].
2. Materials & methods
2.1. Animal tissue
Lung tissue was obtained from 8 to 12weeks old C57BL/6J mice
that were housed under controlled conditions with a 12 h light/dark
cycle and free access to water and food (Central Animal Facility,
University Medical Center Groningen, Groningen, The Netherlands).
Prior to excision, the lungs were inflated in situ with liquefied and pre-
warmed (37 °C) support medium containing 1.5% low-gelling-tem-
perature agarose (Sigma-Aldrich, Zwijndrecht, The Netherlands) and
0.9% NaCl (Merck, Darmstadt, Germany) via a terminal procedure
conducted under isoflurane/O2 anesthesia (Nicolas Piramal, London,
UK). Afterwards, the lungs were immediately transferred to ice-cold
University of Wisconsin (UW) preservation solution (DuPont Critical
Care, Waukegab, USA). All experiments were approved by the Animal
Ethics Committee of the University of Groningen (permit no. 171290-
01-001).
2.2. Precision-cut lung slices
As described previously, slices were made with a Krumdieck tissue
slicer (Alabama Research and Development, Munford, USA), which was
filled with ice-cold Krebs-Henseleit buffer supplemented with 25mM D-
glucose (Merck), 25mM NaHCO3 (Merck), and 10mM HEPES (MP
Biomedicals, Aurora, USA); saturated with carbogen (95% O2 and 5%
CO2); and adjusted to a pH of 7.4 (Fig. 1) [5]. Lung slices had a wet
weight of 4–5mg, with an estimated thickness of 250–350 μm and a
diameter of approximately 5mm. Slices were incubated individually in
1mL pre-warmed and oxygenated culture medium at 37 °C under 80%
O2 and 5% CO2, while gently shaken (90 cycles per minute). Culture
medium was composed of Accell siRNA Delivery Media (Dharmacon,
Lafayette, USA) supplemented with 100 U/mL penicillin–streptomycin
(Life Technologies, Bleiswijk, The Netherlands), 50 μg/mL gentamicin
(Life Technologies), and 0.1mM non-essential amino acids (Life Tech-
nologies). After slicing, slices were sampled directly or pre-incubated
for 2 h in culture medium. Thereafter, slices were transferred to culture
medium without Accell siRNA (untransfected) or with either 0.5 μM
non-targeting (control) Accell siRNA or gene-targeting Accell siRNA
(Gapdh, Ppib, Serpinh1, or Bcl2l1). All Accell siRNAs were purchased
from Dharmacon. After 48 or 96 h of incubation, slices were collected
for analysis.
2.3. ATP content
ATP was extracted from slices (3 per condition) using ice-cold so-
nication solution (70% ethanol and 2mM EDTA) and a Minibead-beater
for homogenization (1 cycle of 1.5min). After centrifuging the homo-
genate (16,000g at 4 °C for 5min), the supernatant was collected and
subsequently analyzed using an ATP Bioluminescence Kit (Roche
Diagnostics, Mannheim, Germany), as reported previously [6]. Ob-
tained ATP values (pmol) were normalized to total amount of protein
(μg), which was determined with the RC DC Protein Assay (Bio-Rad,
Munich, Germany).
2.4. Morphology
After fixation in 4% formalin at 4 °C for 24 h, slices (3 per condition)
were dehydrated in baths with increasing strengths of ethanol.
Thereafter, slices were cleared in xylene baths and embedded hor-
izontally in paraffin. Prior to staining with hematoxylin and eosin (H&
E), sections (4 μm) were deparaffinized and rehydrated in baths with
decreasing strengths of ethanol. Afterwards, sections were dehydrated
in baths of increasing strengths of ethanol. Finally, slides were scanned
with a C9600 NanoZoomer (Hamamatsu Photonics, Hamamatsu,
Japan).
Fig. 1. Slicing workflow. Murine lungs were first inflated in situ with agarose and then excised. Cylindrical tissue cores were subsequently made using a biopsy
puncher with a diameter of ∼5mm. Finally, slices were prepared with a Krumdieck tissue slicer, yielding slices with a thickness of 250–350 μm that can be cultured
ex vivo.
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2.5. mRNA expression
Total RNA was isolated from slices (3 per condition) using a
Maxwell 16 LEV SimplyRNA Tissue Kit (Promega, Leiden, The
Netherlands) and the RNA yield was quantified with a BioTek Synergy
HT (BioTek Instruments, Vermont, USA). Isolated RNA was subse-
quently reverse transcribed with the Reverse Transcription System
(Promega), using a thermal cycler (22 °C for 10min, 42 °C for 15min,
and 95 °C for 5min). Next, mRNA expression was assessed by qPCR,
using specific primers (Table 1) and FastStart Universal SYBR Green
Master (Roche, Almere, The Netherlands). The analysis was performed
with a ViiA7 real-time qPCR (Applied Biosystems, Bleiswijk, The
Netherlands), using 1 cycle of 10min at 95 °C and 40 cycles of 15 s at
95 °C, 30 s at 60 °C, and 30 s at 72 °C. mRNA expression was calculated
as fold induction (2−ΔΔCt method), using Ywhaz as a reference gene.
2.6. Protein expression
GAPDH, PPIB, HSP47, and BCL-XL protein expression was de-
termined by western blotting. In short, protein was extracted from slices
(6–12 per condition) using ice-cold RIPA lysis buffer (Fischer Scientific,
Landsmeer, The Netherlands) and a Minibead-beater for homogeniza-
tion (five cycles of 45 s Minibead-beating and 10min of cooling on ice).
Samples were subsequently centrifuged (16,000g at 4 °C for 30min) and
denatured (75 °C for 15min). Extracted protein (20 μg) was separated
via sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) using 10% gels and blotted onto polyvinylidene fluoride mem-
branes using a Trans-Blot Turbo Transfer System (Bio-Rad). After
blocking in 5% non-fat milk/TBST (Bio-Rad) for 1 h, membranes were
incubated with the primary antibody (Table 2) overnight at 4 °C fol-
lowed by incubation with the respective secondary antibody for 1 h.
Thereafter, protein was visualized with Clarity Western ECL blotting
substrate (Bio-Rad) using the ChemiDoc Touch Imaging System (Bio-
Rad). Protein expression was normalized using housekeeping protein
vinculin (VCL) as internal control.
2.7. Statistics
GraphPad Prism 6.0 was used to analyze data statistically using one-
way analysis of variance (ANOVA) followed by either Tukey’s multiple
comparisons test to compare all means within a dataset or Dunnett’s
multiple comparisons test to compare all means with one control mean.
Note, mRNA expression is shown as fold induction (2−ΔΔCt), though the
data was analyzed using the ΔCt values. Differences between groups
were considered significant when p < .05.
3. Results
3.1. Viability of untransfected slices
First, the general viability and morphology of untransfected slices
were characterized (Fig. 2). As such, we investigated the ATP/protein,
protein, and RNA content as well as the morphology of untransfected
slices at 0 h and after 48 and 96 h of incubation. The ATP/protein
content was significantly higher after the first 48 h of culturing, after
which it appeared to decrease again, albeit not significantly. Further-
more, both protein and RNA content significantly decreased over time.
Generally, the morphology of slices remained good for up to 48 h. After
96 h, signs of moderate apoptosis manifested in the airways and par-
enchyma. In the airways, moderate karyolysis (nuclei dissolution),
pyknosis (nuclei shrinkage), and karyorrhexis (nuclei fragmentation)
were observed. Furthermore, in some cases, airway epithelial cells be-
came squamous (flattened). Karyolysis, pyknosis, and karyorrhexis
were also observed to a moderate extent in the parenchyma, along with
some clusters of apoptotic bodies.
3.2. Viability of transfected slices
Next, we studied whether the use of Accell siRNA affected the via-
bility of lung slices, after an incubation of 96 h, with a focus on ATP/
protein, protein, and RNA content as well as morphology (Fig. 3). As
Table 1
Primers.
Gene Protein Forward sequence (5′→3′) Reverse sequence (5′→3′)
Acta2 α-SMA ACTACTGCCGAGCGTGAGAT CCAATGAAAGATGGCTGGAA
Bcl2l1 BCL-XL ACATCCCAGCTTCACATAACCC CCATCCCGAAAGAGTTCATTCAC
Col1a1 COL1A1 TGACTGGAAGAGCGGAGAGT ATCCATCGGTCATGCTCTCT
Fn FN CGGAGAGAGTGCCCCTACTA CGATATTGGTGAATCGCAGA
Gapdh GAPDH ACAGTCCATGCCATCACTGC GATCCACGACGGACACATTG
Ppib PPIB GGCTCCGTCGTCTTCCTTTT ACTCGTCCTACAGATTCATCTCC
Serpine1 PAI-1 GCCAGATTTATCATCAATGACTGGG GGAGAGGTGCACATCTTTCTCAAAG
Serpinh1 HSP47 AGGTCACCAAGGATGTGGA CAGCTTCTCCTTCTCGTCGT
Tnfrsf11b OPG ACAGTTTGCCTGGGACCAAA CTGTGGTGAGGTTCGAGTGG
Ywhaz 14-3-3ζ TTACTTGGCCGAGGTTGCT TGCTGTGACTGGTCCACAAT
Table 2
Antibodies.
Protein Primary antibody Secondary antibody
BCL-XL
(23 kDa)
Rabbit anti-BCL-XL (1:1000, Fischer Scientific) Goat anti-rabbit HRP (1:2000, Dako, Santa Clara, USA)
GAPDH
(36 kDa)
Mouse anti-GAPDH (1:5000, Sigma Aldrich) Rabbit anti-mouse HRP (1:5000, Dako)
HSP47
(47 kDa)
Rabbit anti-HSP47 (1:2000, Abcam, Cambridge, USA) Goat anti-rabbit HRP (1:2000, Dako)
PPIB
(24 kDa)
Mouse anti-PPIB (1:1000, Fischer Scientific) Rabbit anti-mouse HRP (1:5000, Dako)
VCL
(116 kDa)
Mouse anti-VCL (1:500, Santa Cruz, California, USA) Mouse binding protein HRP (1:1000, Santa Cruz)
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illustrated, transfections with non-targeting, Gapdh-targeting, Ppib-tar-
geting, Serpinh1-targeting, and Bcl2l1-targeting siRNA did not sig-
nificantly change ATP/protein, protein, and RNA content in slices.
Likewise, no substantial differences in the general morphology were
observed between untransfected and transfected slices.
3.3. Baseline mRNA expression in untransfected slices
To avoid silencing genes that are (strongly) down- or upregulated
during incubation, we determined whether the baseline mRNA ex-
pression of Gapdh, Ppib, Serpinh1, and Bcl2l1 in untransfected lung slices
remained stable during an incubation of up to 96 h (Fig. 4). As shown,
the baseline expression of mRNAs targets did not significantly change
over time.
3.4. mRNA knockdown in transfected slices
To determine whether RNA interference was induced, we analyzed
Gapdh, Ppib, Serpinh1, and Bcl2l1 mRNA expression in untransfected
and transfected lung slices which were incubated for 96 h (Fig. 5). As
demonstrated, Gapdh-targeting, Ppib-targeting, Serpinh1-targeting, and
Bcl2l1-targeting siRNA induced significant and specific knockdown of
respective target mRNAs (knockdown of 65, 95, 70, and 45%, respec-
tively, compared to untransfected slices). Furthermore, no non-specific
mRNA knockdown was observed with non-targeting siRNA.
3.5. Protein knockdown in transfected slices
GAPDH, PPIB, HSP47, and BCL-XL protein expression was studied to
determine whether knockdown of the functional gene product was
achieved after an incubation of 96 h (Fig. 6). As shown, Gapdh-tar-
geting, Ppib-targeting, Serpinh1-targeting, and Bcl2l1-targeting siRNA
resulted in significantly lower expression of corresponding protein
targets by 70, 35, 75, and 50%, respectively, compared to untransfected
slices. Furthermore, no non-specific protein knockdown was induced by
non-targeting siRNA.
3.6. Fibrogenesis in untransfected slices
Prior to the actual application of this transfection model within the
context of fibrogenesis, we determined the baseline mRNA expression
of fibrogenesis-related genes (Fig. 7). As such, the mRNA expression of
Fig. 2. Viability of untransfected slices. Untransfected slices were sampled after slicing (0 h) and after an incubation of 48 or 96 h (n=3–6). Aside from ATP/protein
(a), protein (b), and RNA (c) content, the general morphology (magnification 10×) was analyzed at 0 h (d), 48 h (e), and 96 h (f). Values represent individual
experiments performed in triplicate and are accompanied with the arithmetic mean (horizontal line) ± standard error of the mean (error bars). Tukey’s test was used
to compare all means (* p < .05, ** p < .01, and **** p < .0001).
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Serpine1, Tnfrsf11b, Fn, Col1a1, and Acta2 was studied during an in-
cubation of up to 96 h. Over time, mRNA expression of Serpine1,
Tnfrsf11b, and Fn significantly increased, whereas expression of Col1a1
and Acta2 significantly decreased.
3.7. Fibrogenesis in transfected slices
Finally, we determined whether protein knockdown of PPIB,
HSP47, and BCL-XL influenced the expression of fibrogenesis-related
genes (Fig. 8). Therefore, Serpine1, Tnfrsf11b, Fn, Col1a1, and Acta2
Fig. 3. Viability of transfected slices. Untransfected and transfected slices were sampled after an incubation of 96 h (n=3). Thereafter, the ATP/protein (a), protein
(b), and RNA (c) content of slices was assessed. In addition, the general morphology (magnification 10×) of untransfected slices (d) and slices transfected with non-
targeting siRNA (e), Gapdh-targeting siRNA (f), Ppib-targeting siRNA (g), Serpinh1-targeting siRNA (h), and Bcl2l1-targeting siRNA (i) was analyzed. Values (relative
to untransfected slices) represent individual experiments performed in triplicate and are accompanied with the arithmetic mean (horizontal line) ± standard error of
the mean (error bars). Tukey’s test was used to compare all means.
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mRNA expression was examined in untransfected slices and slices
treated with non-targeting, Ppib-targeting, Serpinh1-targeting, and
Bcl2l1-targeting siRNA for 96 h. Compared to slices treated with non-
targeting siRNA, slices treated with Serpinh1-targeting siRNA had sig-
nificantly lower Serpine1 and Tnfrsf11b mRNA expression, whereas
treatment with Ppib-targeting and Bcl2l1-targeting siRNA only resulted
in significantly lower Tnfrsf11b mRNA expression. Fn, Col1a1, and
Acta2 mRNA expression was not significantly different among the dif-
ferent groups.
4. Discussion
The main objective of this study was to investigate whether siRNA-
mediated protein knockdown could be achieved in precision-cut lung
slices using Accell siRNA. To this end, we first characterized viability
parameters of lung slices and subsequently assessed effects of siRNA on
mRNA and protein expression. In general, untransfected and trans-
fected lung slices were shown to remain viable for up to 96 h, with
moderate signs of apoptosis. More importantly, extending the incuba-
tion time to 96 h was shown to generate significant mRNA knockdown,
which also resulted in knockdown of respective proteins. Furthermore,
knockdown of PPIB, HSP47, and BCL-XL was shown to affect mRNA
expression of fibrogenesis-related genes Serpine1 and Tnfrsf11b, thereby
demonstrating the utility of this transfection model to study the role of
genes in a biologically relevant environment.
4.1. Viability
First of all, untransfected lung slices were characterized with respect
to ATP/protein, protein, and RNA content as well as tissue morphology.
Fig. 4. Baseline mRNA expression in untransfected slices. Untransfected slices were sampled after slicing (0 h) and after an incubation of 48 or 96 h (n=3–6). mRNA
expression of Gapdh (a), Ppib (b), Serpinh1 (c), and Bcl2l1 (d) was analyzed by qPCR, using Ywhaz as a reference gene. Values represent individual experiments
performed in triplicate and are accompanied with the arithmetic mean (horizontal line) ± standard error of the mean (error bars). Tukey’s test was used to compare
all means.
Fig. 5. mRNA knockdown in transfected slices. Untransfected and transfected slices were sampled after an incubation of 96 h (n=3). mRNA knockdown of Gapdh
(a), Ppib (b), Serpinh1 (c), and Bcl2l1 (d) was determined by qPCR, using Ywhaz as a reference gene. Values represent individual experiments performed in triplicate
and are accompanied with the arithmetic mean (horizontal line) ± standard error of the mean (error bars). Tukey’s test was used to compare all means (* p < .05
and *** p < .001).
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Although ATP/protein levels in untransfected slices remained relatively
stable over time, the protein and RNA content decreased which suggests
a fraction of cells disappeared (e.g., due to apoptosis) while the re-
maining cells remained viable. Morphological analyses of untransfected
slices revealed similar observations because moderate pyknosis (irre-
versible condensation of chromatin) and karyorrhexis (fragmentation of
nuclei) were observed after 96 h of incubation. In line with our previous
study, signs of apoptosis were not observed after an incubation of 48 h
[5]. Other publications describe permissible incubation times for lung
slices ranging from 24 h up to 15 days, though different viability
parameters were studied [16–21]. This makes comparisons particularly
difficult because not all viability parameters are equally informative.
More importantly, no significant differences were observed in ATP/
protein, protein content, and RNA content between untransfected and
transfected slices after 96 h of incubation. The tissue morphology was
not affected by siRNA transfections either. Previously, we showed
Accell siRNA could be used to transfect murine lung slices (and kidney
slices) without affecting the viability after 48 h of incubation [5]. This
study complements those findings by demonstrating that lung slices
could be incubated with Accell siRNA for an extended period of time
Fig. 6. Protein knockdown in transfected slices. Untransfected and transfected slices were sampled after an incubation of 96 h (n=3). Protein knockdown of GAPDH
(a), PPIB (b), HSP47 (c), and BCL-XL (d) was determined by western blotting, using VCL as a housekeeping protein. Values represent individual experiments
performed in triplicate and are accompanied with the arithmetic mean (horizontal line) ± standard error of the mean (error bars). Tukey’s test was used to compare
all means (* p < .05 and ** p < .01).
Fig. 7. Fibrogenesis in untransfected slices. Untransfected slices were sampled after slicing (0 h) and after an incubation of 48 or 96 h (n=6). mRNA expression of
Serpine1 (a), Tnfrsf11b (b), Fn (c), Col1a1 (d), and Acta2 (e) were analyzed by qPCR, using Ywhaz as a reference gene. Values represent individual experiments
performed in triplicate and are accompanied with the arithmetic mean (horizontal line)± standard error of the mean (error bars). Tukey’s test was used to compare
all means (**** p < .0001).
M.J.R. Ruigrok et al. European Journal of Pharmaceutics and Biopharmaceutics 133 (2018) 339–348
345
(96 h). This finding is important as commonly used membrane-disrup-
tion-mediated (e.g., optoporation, electroporation, and micro-injec-
tions) and carrier-mediated (e.g., viral vectors, lipid-based nano-
particles, and polymer-based nanoparticles) transfection technologies
can have profound cytotoxic effects [22]. Obviously, though the via-
bility of slices was not affected by the Accell siRNAs, care should be
taken not to extrapolate these findings to all potential siRNA targets.
For example, highly efficient knockdown of crucial proteins can po-
tentially have detrimental effects on the viability of slices.
4.2. Knockdown
After confirming stable mRNA expression of Gapdh, Ppib, Serpinh1,
and Bcl2l1 during an incubation of up to 96 h, we observed significant
and specific mRNA knockdown of respective targets using Accell siRNA.
Results presented here build on our previous work by demonstrating
the utility of Accell siRNA to induce transient knockdown of not only
Gapdh but also Ppib, Serpinh1, and Bcl2l1 [5]. Regarding mRNA
knockdown, we observed different efficiencies between the tested
siRNAs. Sources of variation could involve the abundance of targeted
Fig. 8. Fibrogenesis in transfected slices. Untransfected and transfected lung slices were sampled after an incubation of 96 h (n=3). Next, mRNA expression of
Serpine1 (a), Tnfrsf11b (b), Fn (c), Col1a1 (d), and Acta2 (e) was analyzed by qPCR, using Ywhaz as a reference gene. Values represent individual experiments
performed in triplicate and are accompanied with the arithmetic mean (horizontal line)± standard error of the mean (error bars). Dunnett’s test was used to compare
means vs. non-targeting siRNA (* p < .05).
Table 3
Fibrogenesis-related genes.
Gene Expression Function Reference
Acta2 (Myo)fibroblasts Encodes a smooth-muscle protein which promotes wound-repair by contracting edges of wounds Longo et al. (2015) [15]
Col1a1 (Myo)fibroblasts Encodes an important extracellular matrix (ECM) constituent to support closure of wounds Wynn et al. (2012) [14]
Fn (Myo)fibroblasts Encodes a glycoprotein of the ECM which operates as a ligand for cell surface receptors Bonnans et al. (2014) [13]
Serpine1 Endothelial cells
(Myo)fibroblasts
Encodes a serine protease inhibitor that shields ECM proteins from proteolytic degradation Ghosh et al. (2012) [10]
Tnfrsf11b (Myo)fibroblasts
Smooth muscle cells
Encodes a biomarker for transforming growth factor β 1 (TGFβ1) pathway activation Simionescu et al. (2007) [11]
Toffoli et al. (2011) [12]
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mRNA, the efficiency of siRNA sequences, and the applicability of
feedback mechanisms. For example, although siRNA-mediated RNAi is
a catalytic process, knockdown does depend on the number of mRNA
copies – fewer copies are more easily degraded than many copies [23].
Furthermore, the siRNA sequence determines the position where mRNA
cleavage will occur. Depending on the local secondary structure of
mRNA, cleavage can be hampered or promoted [24,25]. Lastly, feed-
back mechanisms, such as micro RNA (miRNA) expression and tran-
scriptional activation, could be triggered upon siRNA-mediated mRNA
knockdown to compensate for changes in mRNA levels [26,27]. These
factors, or a combination thereof, could have contributed to differences
in the extent of mRNA knockdown.
Moreover, we observed significant and specific protein knockdown
in lung slices after an incubation of 96 h. As a result, this transfection
model can be applied to study the effects of siRNA in a relevant bio-
logical environment. Interestingly, except for slices treated with Ppib-
targeting siRNA, protein knockdown after 96 h was approximately si-
milar to respective mRNA knockdown, thereby suggesting equilibra-
tion. Equilibration between mRNA and protein depends on the in-
tracellular half-life, which is determined by protein degradation
kinetics [28]. Perhaps PPIB has a longer intracellular half-life than
GAPDH, HSP47, and BCL-XL. Usually, secreted proteins have different
in vitro degradation kinetics than cytoplasmic proteins. Secreted pro-
teins are generally degraded via lysosomal degradation, whereas cyto-
plasmic proteins are degraded by the ubiquitin-proteasome system
[29]. Unlike GAPDH, HSP47, and BCL-XL, the protein PPIB can be se-
creted by cells via the constitutive secretory pathway either sponta-
neously or as a response to oxidative stress [8,9,30,31]. As such, it is
possible that relevant amounts of PPIB resided in intracellular vesicles
ready for secretion, thus avoiding degradation by the ubiquitin-pro-
teasome system. Further exploration of specific PPIB degradation ki-
netics, however, was beyond the scope of this study.
4.3. Fibrogenesis
As mentioned earlier, we determined whether protein knockdown
of PPIB, HSP47, and BCL-XL affected the fibrogenic phenotype of slices.
First, we assessed the baseline expression of fibrogenesis-related genes,
such as Acta2, Col1a1, Fn, Serpine1, and Tnfrsf11b (Table 3). As de-
monstrated, mRNA expression of Serpine1, Tnfrsf11b, and Fn sig-
nificantly increased, whereas mRNA expression of Col1a1 and Acta2
significantly decreased. This response could have been induced by the
release of pro-fibrogenic factors (e.g., growth factors, proteases, and
metalloproteinases) from the extracellular matrix (ECM) into culture
medium as well as by the release of cytokines by cells. As the slicing
process partially disrupts the ECM, such factors could have diffused into
the medium, potentially leading to activation of, for example, the
transforming growth factor β 1 (TGFβ1) signaling pathway – one of the
key drivers of fibrogenesis [32,33]. Clearly, these changes in mRNA
expression may not fully reflect changes in the expression of functional
gene products (i.e., proteins) but it does provide an indication of an
early fibrogenic response. Lung slices are therefore particularly useful
in fibrosis-related research because they display early signs of fi-
brogenesis as well as acute inflammation, which we observed in our
previous study [5].
Finally, we determined whether knockdown of PPIB, HSP47, and
BCL-XL affected the mRNA expression of fibrogenesis-related genes. As
shown, only Serpine1 and Tnfrsf11b mRNA expression was significantly
affected. Though further elucidation of causative mechanisms was be-
yond the scope of this particular study, we could speculate on relevant
mechanisms. For instance, HSP47 is necessary for the appropriate in-
tracellular folding and trafficking of collagen type 1 in myofibroblasts,
which are key effector cells in fibrogenesis. Accordingly, the knock-
down of HSP47 leads to the accumulation of misfolded procollagens in
the endoplasmic reticulum (ER) [34]. Recent research has shown that
HSP47 knockdown induced ER-stress mediated apoptosis in
myofibroblasts, thereby leading to a lower expression of TGFβ1 [8,35].
A lowered expression of TGFβ1 could have led to a lowered mRNA
expression of Serpine1 and Tnfrsf11b because these genes are involved
in fibrogenesis [10–12]. Nonetheless, although no major inferences can
be made regarding the downstream effects of PPIB, HSP47, and BCL-XL
knockdown in fibrogenesis, the data does illustrate that siRNA-medi-
ated protein knockdown can induce phenotypic changes in lung slices,
thereby demonstrating the potential of this ex vivo transfection model.
To go a step further, the same transfection technique could be applied
to slices prepared from human lung tissue. The preparation of human
lung slices is similar to the slicing procedure presented here, as de-
scribed by others [36,37]. Briefly, after careful inflation of human lung
tissue with agarose via the airways, cylindrical tissue cores can be
prepared with a biopsy puncher, after which slices can be prepared
using a Krumdieck tissue slicer. As a result, the use of human lung tissue
makes this transfection technique even more relevant in translational
research.
5. Conclusion
The principle aim of this present work was to further characterize
and optimize an siRNA transfection model for lung slices to achieve
protein knockdown using Accell siRNA. Overall, lung slices remained
viable after an incubation of 96 h, though signs of apoptosis were ob-
served. In addition, the viability of slices was not significantly affected
by transfections with Accell siRNA. More importantly, gene-targeting
siRNAs induced not only significant and specific knockdown of mRNA
levels but also knockdown of respective proteins. In the context of fi-
brogenesis, this model was also applied to study whether protein
knockdown resulted in phenotypic changes. As shown, PPIB, HSP47,
and BCL-XL knockdown affected mRNA expression of fibrogenesis-re-
lated genes (Serpine1 and Tnfrsf11b). Collectively, the results illustrate
that this ex vivo transfection model can be used to study the effects of
siRNA in a biologically relevant environment. Moreover, the same
transfection technique could be applied to lung slices prepared from
human tissue, thereby further expanding the model its utility in trans-
lational research.
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